DBT Bureau
Bengaluru, 2 July 2025
Nymi, an Innominds company, has announced a strategic partnership with Caliber Technologies to accelerate digital transformation in pharmaceutical manufacturing by enabling passwordless authentication on the shop floor.
This collaboration strengthens MES, LIMS, and QMS automation by reducing manual logins and streamlining electronic signatures—key steps in regulated environments where compliance and productivity must go hand in hand.
The Nymi Band is a biometric, wearable device that authenticates users via fingerprint and facilitates a secure, continuous identity across applications, systems, and physical environments. It replaces traditional password entry with a contactless and hands-free tap, while delivering a Multi-Factor Authentication (MFA) experience that is user-friendly and supports regulatory compliance.
Together, Nymi and Caliber are defining the next phase of pharma digitalization and delivering more secure, efficient, and human-centric workflows across Research & Development labs and manufacturing operations. This partnership represents a step forward in how the world’s leading pharmaceutical manufacturers are building the connected workforce of the future.
Commenting on the partnership Ratnakar Palakodeti, President – Healthcare & Life Sciences, Innominds, said: “This partnership with Caliber Technologies marks a pivotal moment in our mission to engineer intelligence responsibly in life sciences. By combining Innominds’ deep expertise in secure digital platforms with Caliber’s proven solutions and Nymi’s wearable authentication technology, we are redefining how pharmaceutical companies ensure compliance, improve productivity, and safeguard data integrity—especially in regulated environments.”
Highlighting the strategic collaboration, David Fortune, President, Nymi, said: “At Nymi, we are committed to advancing secure, seamless, and user-centric solutions for the life sciences industry. Collaborating with Caliber and leveraging the scale of Innominds allows us to extend the reach of our wearable-enabled biometric authentication to more pharmaceutical organizations. Together, we are enabling true digital transformation by ensuring compliance, reducing human error, and delivering frictionless user experiences across connected workflows.”
Speaking about the collaboration, Sekhar Surabhi, CEO and Founder, Caliber Technologies, said: “We are excited to partner with Innominds in our mission to drive digital transformation in the pharmaceutical industry. Building on our life sciences regulatory compliant products and existing work with GenAI, this collaboration will empower pharmaceutical companies to embrace next-generation technologies, streamline processes, and achieve unparalleled levels of compliance and operational efficiency across the quality management value chain.”
